bioMARkers and molecular tumor classification for non-genotoxic CARcinogenesis

Project Information

MARCAR

Grant agreement ID: 115001

Project closed

Start date 1 January 2010

End date 30 June 2015

Funded under

• Specific Programme "Cooperation": Joint Technology Initiatives

Total cost € 13 110 690,00

EU contribution € 6 049 578,00

Coordinated by

NOVARTIS PHARMA AG
Switzerland

• A faster way to spot the tell-tale signs of cancer-causing drugs
  EN